Allarity Therapeutics, Inc. Common Stock (ALLR) is a publicly traded Healthcare sector company. As of August 14, 2026, ALLR trades at $1.39 with a market cap of $22.28M and a P/E ratio of -1.94. ALLR moved +1.84% today. Year to date, ALLR is +19.30%; over the trailing twelve months it is +36.01%. Its 52-week range spans $0.61 to $2.35. Analyst consensus is buy with an average price target of $10.25. Rallies surfaces ALLR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ALLR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.39 |
| Market Cap | $22.28M |
| P/E Ratio | -1.94 |
| EPS | $-0.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.35 |
| 52-Week Low | $0.61 |
| Volume | 845 |
| Avg Volume | 0 |
| Revenue (TTM) | $345.00K |
| Net Income | $-11.25M |
| Gross Margin | 0.00% |
1 analysts cover ALLR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.25.